Retaglutide and tirzepatide are innovative GLP-1 receptor agonists gaining popularity as effective treatment options for type 2 diabetes. These medications enhance insulin secretion from the pancreas, suppress glucagon https://aprildmmi496406.wikipresses.com/6776115/emerging_therapies_for_type_2_diabetes